The Cutting Edge Veterinary Podcast
Episode 9: Exploring Controversies in the Management of Feline Urethral Obstruction
STUDENT(S): Alex Ferguson, Kaitlyn Dvorack, and Alex Hibberd
FACULTY MENTOR(S): Dr. Soren Boysen
ABSTRACT
Feline urethral obstruction (UO) is a life-threatening component of feline lower urinary tract disease (FLUTD) accounting for a high number of cases presenting to veterinary ER services. Treatment of feline UO generally includes stabilization through intravenous fluid administration, correction of hyperkalemia and urinary catheter placement. Despite well-established basics in treatment plans, there are many controversial debates surrounding the optimal approach for addressing feline UO and preventing recurrent obstructions. Three of the major controversies include decompressive cystocentesis prior to unblocking procedures, cystocentesis without pursuing unblocking, and the use of prazosin to decrease the incidence of recurrent urinary obstructions. This review explores these three controversies in detail based on the available literature. Decompressive cystocentesis may be indicated for patients presenting too unstable for immediate urinary catheter placement. Decompressive cystocentesis as sole therapy should not be offered as first line treatment to feline UO patients, however, it may be an alternative to euthanasia for clients with financial restrictions. Prazosin has long been recognized as a drug to prevent recurrent urethral obstructions; however, based on the available literature there is little evidence to support this claim. In all cases, client communication and consideration of clinical presentation are essential for making treatment decisions.
Release date:
29 September 2024